The Sei Foundation, the nonprofit development organization behind the layer-1 blockchain Sei (SEI), is exploring the acquisition of bankrupt personal genomics company 23andMe and putting the genetic data of 15 million users on blockchain rails.

The foundation announced the initiative in an X post on Thursday, calling the plan its “boldest DeSci bet yet” — referring to the decentralized science movement. Earlier this year, it also launched a $65 million venture capital fund dedicated to DeSci startups building on the Sei network.

The foundation said that genomic data security is a national security matter, particularly as 23andMe grapples with financial difficulties. The company, known for its direct-to-consumer DNA testing services, filed for Chapter 11 bankruptcy protection earlier this week.

If the acquisition proceeds, the Sei Fundation plans to integrate 23andMe’s data onto its blockchain and give users ownership of their genetic data, ensuring privacy through encrypted transfers and allowing individuals to decide how their data is monetized.

“This isn’t just about saving a company, it’s about building a future where your most personal data remains yours to control,” the foundation said.

Numerous state attorneys general have warned 23andme customers to delete their data from the platform in recent days since the company’s bankruptcy filing.

SEI, the native token of the network, climbed as much as 3% following the news before giving back some of the gains.

The German financial supervisory authority BaFin said it identified “serious deficiencies” in Ethena’s USDe token, which the company calls a synthetic dollar, and forbade the issuer from offering it to the public with immediate effect.

The European Union’s Market in Crypto Assets (MiCA) regulations for issuers of stablecoins, tokens whose value is tied to another asset, took effect on June 30 last year. Ethena GmbH has been issuing USDe since June 28, according to BaFin. Companies were allowed to continue issuing their tokens while applying for a MiCA license, unless ordered to stop.

“During the ongoing licensing process, BaFin has identified, among other things, serious deficiencies in the bank’s business organization and violations of MiCAR requirements, such as those regarding asset reserves and compliance with capital requirements,” the regulator said.

USDe counts as an asset-referenced token because it is “a crypto asset whose value stability is to be maintained by reference to other assets, rights, or currencies,” BaFin said.

Ethena is the yield-generating protocol that markets the $5.4 billion token as a “synthetic dollar” with its price anchored at $1. The token uses cryptocurrencies including bitcoin (BTC) and ether (ETH) as backing assets, pairing them with an equal value of short perpetual futures positions on various exchanges.

The strategy generates income for the protocol when perpetual funding rates are positive and passes on some of the income as yield to those who stake USDe (sUSDe). The protocol also issues the USDtb stablecoin, backed by BlackRock’s tokenized Treasury bill fund.

“BaFin also has reasonable grounds to suspect that Ethena GmbH is publicly offering securities in Germany in the form of ‘sUSDe’ tokens of Ethena OpCo. Ltd. without the required securities prospectus,” the regulator said.

Ethena said on X that it will “continue to evaluate alternative frameworks,” after being notified that the “application under the MiCAR regulatory framework will not be approved.”

Ethena’s governance token, ENA, had dropped 6.5% in the past 24 hours, extending losses following the announcement, according to CoinMarketCap data.

Krisztian Sandor contributed to this article.

UPDATE (March 21, 16:37 UTC): Adds MiCA in second paragraph, regulator quote in third, USDe explanation starting in fifth.